IFLR1000

Allergan $2.48 billion acquisition of Zeltiq Aesthetics

13/2/2017
Public acquisition
Select tab

$ 2.48 billion

Announced

13/2/2017

Overview:

  • Dublin-based pharmaceutical company Allergan has acquired non-invasive fat reduction procedure creator Zeltiq Aesthetics in a $2.48 billion deal.
  • Allergan paid $56.50 per Zeltiq share.
  • Moelis & Co acted as financial adviser for Allergan and Guggenheim Securities acted for Zeltiq.
  • The transaction is expected to close in the second half of this year.

Kurt Stumpo - Journalist

Jurisdictions:

United States
Ireland

Deal type:

Public acquisition

Practice area:

M&A

Industry sector:

Pharmaceuticals and life sciences

Firms:
Cooley

Party: Zeltiq Aesthetics (Target)

Lawyer: Barbara Borden

Debevoise & Plimpton

Party: Allergan (Acquirer)

Lawyers: Andrew Bab, Jennifer Chu

Related deals